Company / Capital Expenditures
Labcorp Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$434.5M
FY2025
5-year range
$421.5M / $489.9M
FY2021-FY2025
Trend
-11.3%
vs FY2024
Sector context
#27 of 151
Health Care
What the data says
Labcorp's capital expenditures of $435M is higher than 82% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $279M in FY2016 to $490M in FY2024.
Based on SEC 10-K filings.
$435M in FY2025 with a 5-year CAGR of +2.7%. Top quartile in the Health Care sector.
Declined from $454M to $435M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- +2.7%
- 10-Year CAGR
- -
Sector benchmark
+59.9% above sector average
Key checks
Key Insights
- 5-year CAGR of +2.7%, indicating consistent growth.
- In FY2025, capital expenditures decreased 11.3% year-over-year.
- Ranks #27 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $434.5M | -11.3% |
| FY2024 | $489.9M | +8.0% |
| FY2023 | $453.6M | +5.7% |
| FY2022 | $429.3M | +1.9% |
| FY2021 | $421.5M | +11.0% |
| FY2020 | $379.8M | -5.1% |
| FY2019 | $400.2M | +5.4% |
| FY2018 | $379.8M | +21.4% |
| FY2017 | $312.9M | +12.2% |
| FY2016 | $278.9M | +9.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026